Articulate Labs

Executive Summary

Articulate Labs is a digital health and medical device company pioneering movement-driven rehabilitation technology. Its flagship product, KneeStim™, is a wearable neuromuscular electrical stimulation (NMES) system that delivers gait-synchronous therapy during everyday walking, enabling patients to undergo rehabilitation outside clinical settings. The company aims to transform recovery by seamlessly integrating personalized, adaptive therapy into daily life, addressing the limitations of static in-clinic sessions. With a focus on knee rehabilitation, KneeStim has the potential to improve patient compliance and outcomes. The company operates in the growing digital health and wearable medical device market, targeting post-surgical and chronic knee conditions. While still in pre-revenue stage, Articulate Labs has a compelling value proposition and a differentiated approach. However, regulatory clearance and clinical validation remain key hurdles. The conviction score reflects the promising technology balanced by the early-stage nature and market adoption risks.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Clearance for KneeStim70% success
• Q3 2026Publication of Clinical Trial Results80% success
• Q2 2026Strategic Partnership with Major Rehabilitation Network50% success